Join Impilo as a Part-Time Investment Analyst! Are you passionate about healthcare investing and eager to gain hands-on experience in private equity? Impilo is looking for a part-time Investment Analyst to join our Copenhagen office. As part of our cross-Nordic internship program, you will work alongside a team of 18 investment professionals, gaining valuable insights into financial modeling, market research, valuation, and strategic advisory for portfolio companies. What we are looking for: - Excellent academic credentials - Strong analytical skills and a passion for investing - Proficiency in Excel and PowerPoint - At least two years of university studies completed What we offer: - A dynamic, fast-paced learning environment - First-hand experience in Nordic healthcare investments - A flexible workweek (15-20 hours) to balance with your studies Apply by February 28th by sending your CV, cover letter, and grade transcript to recruitment@impilo.dk For any questions, feel free to reach out to Alexander From (alexander.from@impilo.se) or Olga Court-Payen (olga.court-payen@impilo.se).
Om oss
Impilo is a Nordic investment company focused solely on investments in companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Our starting point is that our portfolio companies must contribute to a positive and sustainable development of the communities and markets in which they operate in order to remain successful in the long term. This is a conviction that is embedded in our investment strategy since it necessitates a deeper understanding and reduces risks. This way, Impilo invests in people’s opportunities to enjoy healthier lives in the future.
- Webbplats
-
http://www.impilo.se/en/
Extern länk för Impilo
- Bransch
- Riskkapitalister
- Företagsstorlek
- 11–50 anställda
- Huvudkontor
- Stockholm
- Typ
- Privatägt företag
- Grundat
- 2017
- Specialistområden
- Healthcare, Pharma, Medical device, Diagnostics, Healthcare IT, Investments, Care services, Healthcare services, Consumer health och Preventive health services
Adresser
-
Primär
Holländargatan 20
Stockholm, 111 60, SE
-
Kongens Nytorv 28
Copenhagen, 1050, DK
Anställda på Impilo
Uppdateringar
-
Female and interested in learning more about Private Equity? Applications are now open for the Private Equity Female Academy 2025 in Copenhagen! The programme is aimed at female students interested in private equity and will feature five events with the purpose of inspiring and connecting young talent to the industry. Make sure to apply by 22 December via this link: https://lnkd.in/gz8mQfKc
-
As of November 1st Impilo signed up as a Level20 sponsor that is a not-for-profit organisation founded with the aim of improving gender diversity in the private equity industy. The mission is to inspire women to join and succeed in the industry by promoting and retaining female talent. The overall goal of the organisation is for women to hold at least 20% of senior positions in private equity - by working with industry leaders to make the changes necessary for diversity and inclusion to flourish. We look very much forward to our collaboration with Level20 going forward 🙌 🍀
We are delighted to welcome Impilo as a Level 20 sponsor supporting #genderdiversity in #privateequity.
-
-
🏆 We're thrilled to bring home the trophy! 🏆 Super happy to once again be part of a fantastic event organized by White & Case LLP, challenging our industry colleagues in a fun and (mostly) friendly football tournament. Very proud to this year be declared the winner out of 16 attending teams! Impilo has chosen to donate the price money to an organization we have been supporting for several years, En Frisk Generation, which contributes strongly to society in promoting a healthy lifestyle for all. We will continue our mission of investing in a healthy future, as well as investing in developing our football skills to defend the title next year!
Partner at White & Case (Cross-border M&A / Private Equity) | MBA (With Distinction), London Business School
Certain days at the job makes you feel better - e.g. when you, together with the winner of White & Case LLP's Nordic Private Equity Football Tournament, Impilo, just donated the price money from the 2024 tournament to En Frisk Generation - who promote a healthy lifestyle for all children. We think it is a great choice of charity by Impilo and we hope that the money will come to good use with En Frisk Generation - if a healthy lifestyle can be achieved in generations to come - we all be winners! And of course a special thanks to all the other teams EQT Group, Alder / Nalka, Summa Equity, Axcel , Verdane , Cevian Capital , Urban Partners , Altor Equity Partners , Nordic Capital , FSN Capital Partners , Polaris Private Equity , IK Partners , Fidelio Capital , Triton Partners and Adelis Equity Partners who participated (an fought well) in this year's tournament and who contributed their participation fees to the charity of the winner's choice.
-
-
Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization (“CRO”), well recognized for its high-quality genetic toxicology services and strong scientific engagement. Read the full announcement below.
-
Join our team in Copenhagen! We are looking for a talented student for a part-time position as Private Equity Junior Analyst. Applications will be reviewed on a rolling basis but please submit your application no later than 8th of September to recruitment@impilo.dk Should you have any questions, please feel free to reach out.
-
KKR and Impilo announce strategic partnership together with management in rare disease platform Immedica Pharma Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products. Existing owner, Nordic healthcare investment firm Impilo, will reinvest to become an equal owner alongside KKR. The transaction is subject to customary regulatory and closing conditions. Read more here: https://lnkd.in/gcrBDzgW
-